Cargando…

Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer

Programmed death ligand 1 (PD-L1) is overexpressed in the most aggressive breast cancer subtype, triple-negative breast cancer (TNBC), assisting the eradication of antitumor immunity, and thereby enhancing the survival of the tumor. This study explored how hesperidin affects PD-L1 expression, and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kongtawelert, Prachya, Wudtiwai, Benjawan, Shwe, Thuzar Hla, Pothacharoen, Peraphan, Phitak, Thanyaluck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024188/ https://www.ncbi.nlm.nih.gov/pubmed/31936263 http://dx.doi.org/10.3390/molecules25020252

Ejemplares similares

Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells
por: Shwe, Thuzar Hla, et al.
Publicado: (2021)

Anticancer Activities of Hesperidin via Suppression of Up-Regulated Programmed Death-Ligand 1 Expression in Oral Cancer Cells
por: Wudtiwai, Benjawan, et al.
Publicado: (2021)

Sesamin protects against neurotoxicity via inhibition of microglial activation under high glucose circumstances through modulating p38 and JNK signaling pathways
por: Kongtawelert, Prachya, et al.
Publicado: (2022)

Sesamin Attenuates VEGFA-Induced Angiogenesis via Inhibition of Src and FAK Signaling in Chick Chorioallantoic Membrane Model and Human Endothelial EA.hy926 Cells
por: Keratibumrungpong, Tanyaporn, et al.
Publicado: (2023)

Comparison of glucose derivatives effects on cartilage degradation
por: Phitak, Thanyaluck, et al.
Publicado: (2010)

Comparison of growth factor adsorbed scaffold and conventional scaffold with growth factor supplemented media for primary human articular chondrocyte 3D culture
por: Klangjorhor, Jeerawan, et al.
Publicado: (2014)

Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M
por: Khansai, Manatsanan, et al.
Publicado: (2016)

Sesamin Promotes Neurite Outgrowth under Insufficient Nerve Growth Factor Condition in PC12 Cells through ERK1/2 Pathway and SIRT1 Modulation
por: Udomruk, Sasimol, et al.
Publicado: (2020)

Targeting Human Osteoarthritic Chondrocytes with Ligand Directed Bacteriophage-Based Particles
por: Chongchai, Aitthiphon, et al.
Publicado: (2021)

Effects of sesamin on primary human synovial fibroblasts and SW982 cell line induced by tumor necrosis factor-alpha as a synovitis-like model
por: Khansai, Manatsanan, et al.
Publicado: (2017)

Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways
por: Banjerdpongchai, Ratana, et al.
Publicado: (2015)

Chondroprotective effects of purple corn anthocyanins on advanced glycation end products induction through suppression of NF-κB and MAPK signaling
por: Chuntakaruk, Hathaichanok, et al.
Publicado: (2021)

Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes
por: Phimphilai, Mattabhorn, et al.
Publicado: (2021)

Methoxyflavone derivatives modulate the effect of TRAIL-induced apoptosis in human leukemic cell lines
por: Wudtiwai, Benjawan, et al.
Publicado: (2011)

Effects of sesamin on chondroitin sulfate proteoglycan synthesis induced by interleukin-1beta in human chondrocytes
por: Srisuthtayanont, Warunee, et al.
Publicado: (2017)

Receptors of Advanced Glycation End Product (RAGE) Suppression Associated With a Preserved Osteogenic Differentiation in Patients With Prediabetes
por: Phimphilai, Mattabhorn, et al.
Publicado: (2022)

The trajectory of osteoblast progenitor cells in patients with type 2 diabetes and the predictive model for their osteogenic differentiation ability
por: Phimphilai, Mattabhorn, et al.
Publicado: (2023)

Alteration of chondroitin sulfate composition on proteoglycan produced by knock-in mouse embryonic fibroblasts whose versican lacks the A subdomain
por: Suwan, Keittisak, et al.
Publicado: (2009)

Sesamin stimulates osteoblast differentiation through p38 and ERK1/2 MAPK signaling pathways
por: Wanachewin, Orawan, et al.
Publicado: (2012)

The effect of doxycycline on canine hip osteoarthritis: design of a 6-months clinical trial
por: Nganvongpanit, Korakot, et al.
Publicado: (2009)

Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models
por: Yati, Su, et al.
Publicado: (2022)

Comparisons between two biochemical markers in evaluating periodontal disease severity: a cross-sectional study
por: Khongkhunthian, Sakornrat, et al.
Publicado: (2014)

Sesame Extract Promotes Chemopreventive Effect of Hesperidin on Early Phase of Diethylnitrosamine-Initiated Hepatocarcinogenesis in Rats
por: Khuanphram, Napaporn, et al.
Publicado: (2021)

Biochemical and Clinical Assessments of Segmental Maxillary Posterior Tooth Intrusion
por: Tasanapanont, Jintana, et al.
Publicado: (2017)

Hyaluronan production and chondrogenic properties of primary human chondrocyte on gelatin based hematostatic spongostan scaffold
por: Klangjorhor, Jeerawan, et al.
Publicado: (2012)

Prospective evaluation of serum biomarker levels and cartilage repair by autologous chondrocyte transplantation and subchondral drilling in a canine model
por: Nganvongpanit, Korakot, et al.
Publicado: (2009)

Osteosarcoma-Specific Genes as a Diagnostic Tool and Clinical Predictor of Tumor Progression
por: Sittiju, Pattaralawan, et al.
Publicado: (2022)

Subtle inflammation: a possible mechanism of future cardiovascular risk in obese children
por: Sontichai, Watchareewan, et al.
Publicado: (2017)

In vitro suppression of the MMP-3 gene in normal and cytokine-treated human chondrosarcoma using small interfering RNA
por: Nganvongpanit, Korakot, et al.
Publicado: (2009)

Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
por: Botti, Gerardo, et al.
Publicado: (2017)

Programmed death ligand 1 (PD-L1) expression in parathyroid tumors
por: Pan, Boju, et al.
Publicado: (2019)

Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis
por: Delgado, Ronan Jacques Rezende, et al.
Publicado: (2019)

Programmed death-ligand 1 (PD-L1) expression in various tumor types
por: Grosso, Joseph, et al.
Publicado: (2013)

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
por: Núñez Abad, Martín, et al.
Publicado: (2022)

In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
por: Reddy, Vishwanatha R. A. P., et al.
Publicado: (2019)

Molecular dynamics study on the strengthening behavior of Delta and Omicron SARS-CoV-2 spike RBD improved receptor-binding affinity
por: Kodchakorn, Kanchanok, et al.
Publicado: (2022)

Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer
por: Zhang, Jian, et al.
Publicado: (2019)

Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
por: Song, Joon Seon, et al.
Publicado: (2019)

The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor
por: Brinch, Charlotte Margareta, et al.
Publicado: (2022)

Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1)
por: Zak, Krzysztof M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c5iab7sho9607kj4qk90am2ucu